Companhia Brasileira de Distribuicao CBDBY
0.66
0.00
0.00%
as of 24 Dec
- Market cap
- $218.1M
- P/E
- 0.0×
Follow CBDBY
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | — | — | 0.10 | |
P/FCF ratio |
— | — | — | 2.19 | |
P/Operating CF |
— | — | — | 4.86 | |
P/B ratio |
— | — | — | 0.68 | |
Price to Tangible BV |
— | — | — | 1.74 | |
EV/Sales |
— | — | — | 0.25 | |
EV/EBITDA |
— | — | — | 4.89 | |
EV/Operating CF |
— | — | — | 3.18 | |
EV/FCF |
— | — | — | 5.37 | |
Quick Ratio |
0.21 | 0.24 | 0.45 | 0.36 | |
Current Ratio |
0.51 | 0.56 | 0.83 | 0.70 | |
Net Debt/EBITDA |
9.05 | (30.53) | (18.32) | 7.79 | |
Debt/Assets |
27.34% | 25.82% | 24.34% | 22.23% | |
Debt/Equity |
10.58 | 6.12 | 2.11 | 1.49 | |
Asset Turnover |
1.08 | 1.08 | 0.98 | 0.98 | |
Operating CF/Net income |
(0.57) | 0.49 | (1.85) | 2.85 | |
Capex/Depreciation |
(0.30) | (0.24) | (0.29) | (0.30) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
20.61% | 20.96% | 18.40% | 19.53% | |
Intangible Assets out of Total Assets |
0.05 | 0.06 | 0.09 | 0.09 | |
Share Based Compensation of Revenue |
(0.03%) | (0.18%) | (0.18%) | 0.05% | |
Graham Net Nets |
— | — | — | (5.76) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
— | — | — | (71.87%) | |
Free Cash Flow Yield |
— | — | — | 45.58% | |
Revenue per Share |
1.65 | 1.69 | 1.93 | 1.71 | |
Operating CF per Share |
0.06 | (0.27) | 0.40 | 0.14 | |
Capex per Share |
(0.03) | (0.03) | (0.03) | (0.03) | |
Free Cash Flow per Share |
0.03 | (0.30) | 0.37 | 0.11 | |
Cash per Share |
0.26 | 0.37 | 0.74 | 0.51 | |
Shareholders Equity per Share |
0.16 | 0.26 | 0.78 | 1.01 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.16 | 0.26 | 0.78 | 1.01 | |
Free Cash Flow |
13.61 | (146.60) | 180.68 | 52.58 | |
Working Capital |
(816.34) | (742.51) | (219.22) | (373.26) | |
Capital Expenditures |
(14.59) | (12.91) | (13.73) | (17.04) | |
Net Current Asset Value |
(2,186.60) | (2,003.26) | (1,870.16) | (1,949.28) | |
EV/EBIT |
— | — | — | 0.00 | |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.02 | |
Net Profit Margin |
(6.01%) | (32.85%) | (11.08%) | 2.92% | |
Price to Operating Income |
— | — | — | 0.00 | |
| Other line items | |||||
Average Receivables |
201.64 | 187.06 | 204.69 | 202.27 | |
Average Payables |
435.70 | 466.38 | 580.26 | 477.67 | |
Average Inventory |
349.93 | 367.58 | 362.48 | 356.17 | |
Average Assets |
3,187.51 | 3,187.90 | 3,476.52 | 3,439.60 | |
Average Common Equity |
266.74 | 301.52 | 462.28 | 611.80 |
Columns are period end dates